Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at HC Wainwright from $101.00 to $124.00. They now have a "buy" rating on the

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report